
Protai
AI-driven platform for protein-level disease mapping and drug discovery.
About
Protai has developed an end-to-end AI-based platform designed to comprehensively map the progression of diseases at the protein level. This enhances the observation of cellular functions and aims to revolutionize the drug discovery process.
Key facts
At-a-glance profile data
- Website
- protai.bio
- Headquarters
- Tel Aviv, Israel
- Founded
- 2021
- Employees
- 28
- Total funding
- $20M (Seed)
- Business model
- B2B
Funding rounds
Tech stack
Detected on protai.bio, last scanned 13 Sept 2026. Run your own scan
- CMS / Builders
- Lovable
- CDN
- Cloudflare
- Email provider
- Google Workspace
Add first review
Frequently asked
How much funding has Protai raised?
Protai has raised a total of $20M in funding. The most recent round on record is Seed.
How many employees does Protai have?
Protai has approximately 28 people on record.
